Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus
Jose Pablo Maroto, Gary Hudes, Janice P Dutcher, et al.
Surgical Infections
|
March 1, 2021
Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections
Therese M Duane, Jared M Huston, Morgan Collom, et al.
Cancer
|
October 27, 2017
Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy
Hagop M Kantarjian, Carla M Mamolo, Carlo Gambacorti-Passerini, et al.
Annals of Surgical Oncology
|
January 9, 2008
An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection
Jonathan Hernandez, Sarah M Cowgill, Sam Al-Saadi, et al.
The American Journal of Gastroenterology
|
April 26, 2006
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
Klaus R Herrlinger, Thomas Witthoeft, Andreas Raedler, et al.
Melanoma Research
|
May 13, 2022
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma
Zachary Wolfe, Julie C Friedland, Sarah Ginn, et al.
American Journal of Hematology
|
June 5, 2015
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
Carlo Gambacorti-Passerini, Hagop M Kantarjian, Dong-Wook Kim, et al.
Journal of the American Geriatrics Society
|
January 31, 2022
Pilot and feasibility deployment of an advanced remote monitoring platform for COVID-19 in long-term care facilities
Jessica R Walter, Dong-Hyun Kim, Daniel Myers, et al.
British Journal of Haematology
|
November 6, 2015
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
Tim H Brümmendorf, Jorge E Cortes, Hanna J Khoury, et al.
Nature Chemical Biology
|
February 6, 2023
Programmable synthetic biomolecular condensates for cellular control
Yifan Dai, Mina Farag, Dongheon Lee, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus
Jose Pablo Maroto, Gary Hudes, Janice P Dutcher, et al.
Surgical Infections
|
March 1, 2021
Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections
Therese M Duane, Jared M Huston, Morgan Collom, et al.
Cancer
|
October 27, 2017
Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy
Hagop M Kantarjian, Carla M Mamolo, Carlo Gambacorti-Passerini, et al.
Annals of Surgical Oncology
|
January 9, 2008
An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection
Jonathan Hernandez, Sarah M Cowgill, Sam Al-Saadi, et al.
The American Journal of Gastroenterology
|
April 26, 2006
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
Klaus R Herrlinger, Thomas Witthoeft, Andreas Raedler, et al.
Melanoma Research
|
May 13, 2022
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma
Zachary Wolfe, Julie C Friedland, Sarah Ginn, et al.
American Journal of Hematology
|
June 5, 2015
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
Carlo Gambacorti-Passerini, Hagop M Kantarjian, Dong-Wook Kim, et al.
Journal of the American Geriatrics Society
|
January 31, 2022
Pilot and feasibility deployment of an advanced remote monitoring platform for COVID-19 in long-term care facilities
Jessica R Walter, Dong-Hyun Kim, Daniel Myers, et al.
British Journal of Haematology
|
November 6, 2015
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
Tim H Brümmendorf, Jorge E Cortes, Hanna J Khoury, et al.
Nature Chemical Biology
|
February 6, 2023
Programmable synthetic biomolecular condensates for cellular control
Yifan Dai, Mina Farag, Dongheon Lee, et al.
Page
of 6